Standout Papers
Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
2011
Primary Prevention of Ischemic Stroke
2006
Guidelines for the Prevention of Stroke in Women
2014
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes
2012
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
2008
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
2018
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
2010
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
2011
Cardiac Care for Older Adults
2011
Effects of statins on the progression of cerebral white matter lesion
2009
The safety of statins in clinical practice
2007
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke
2005
Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
2009
Drug Treatment of Hyperlipidemia in Women
2004
Impact of Transesophageal Echocardiography on Management in Patients With Suspected Cardioembolic Stroke
2014
Vascular dementia
2015 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
2010
Low density lipoprotein cholesterol, statins and cardiovascular events: a meta–analysis
2006
Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study
2005
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Stroke prevention, blood cholesterol, and statins
2004
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation
2018
The metabolic syndrome
2010 Standout
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
2004
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
2009
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The Association Between Lipid Levels and the Risks of Incident Myocardial Infarction, Stroke, and Total Mortality: The Cardiovascular Health Study
2004
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer
2007
Age and gender bias in statin trials
2001
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial
2017
Modern concept of vascular cognitive impairment
2007
Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
2008
Intensive Statin Therapy and the Risk of Hospitalization for Heart Failure After an Acute Coronary Syndrome in the PROVE IT–TIMI 22 Study
2006
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
2003
Guidelines for the Primary Prevention of Stroke
2010
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936
2012
Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
2010
Meta‐analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
2004
BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities
2016
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
2006
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2007
Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men
2011
Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins
2010
Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis
2015
The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
2008
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study
2012
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
2010
Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
2010
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
2009
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
2004
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
2012
Multiple Pathologies are Common in Alzheimer Patients in Clinical Trials
2012
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
2006
Statin Use and Incident Frailty in Women Aged 65 Years or Older: Prospective Findings From the Women's Health Initiative Observational Study
2008
Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis
2008
White matter changes and late-life depressive symptoms
2007
Statin Safety: A Systematic Review
2006
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years of Age or Older with Stable Coronary Heart Disease
2007
Primary Prevention of Cardiovascular Disease with Statins in the Elderly
2014
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis
2011
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin
2011
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Alzheimer's Disease
2010 Standout
The relation between white-matter lesions and cognition
2007
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
New and emerging data from clinical trials of statins
2004
Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy
2005
Statins and All-Cause Mortality in High-Risk Primary Prevention
2010
Safety of Aggressive Lipid Management
2007
Statin-Associated Myopathy
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
2012
Pleiotropic Effects of Statins
2010
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
2009
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)
2004
Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
2013
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy
2010
Cardiovascular risk factors and dementia
2008
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Alzheimer's disease: the cholesterol connection
2003
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
White Matter Lesions and Brain Atrophy: More than Shared Risk Factors? A Systematic Review
2009
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Statins and the Risk of Colorectal Cancer
2005
Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression
2004
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
2004
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals
2005
Statins: An essential component in the management of carotid artery disease
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
2010
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
2005
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Statin Therapy and the Risk of Intracerebral Hemorrhage
2012
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Pravastatin and the Development of Diabetes Mellitus
2001
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
2005
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial
2001
Periventricular White Matter Lucencies Relate to Low Vitamin B12 Levels in Patients With Small Vessel Stroke
2009
Guidelines for the Primary Prevention of Stroke
2014 Standout
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
2011
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics
2008
Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis
2005
Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly
2005
Statins for the primary prevention of cardiovascular disease
2013
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Prevention of Vascular Cognitive Impairment
2012
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population
2012
Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein
2009
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction
2020
Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation
2003
Total Cerebral Blood Flow and Total Brain Perfusion in the General Population: The Rotterdam Scan Study
2007
Definition and Evaluation of Transient Ischemic Attack
2009
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
2010
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association
2017
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Mild cognitive impairment
2005
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2014
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Progression of Leukoaraiosis and Cognition
2007
Progression of white matter hyperintensities in elderly individuals over 3 years
2007
Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period
2008
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
2016
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial
2003
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
2008
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
2012
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
2016
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
2003
Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
2012
Works of Edward Bollen being referenced
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
2002
Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease. The PROSPER Study
2006
The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
1999
Decline in Total Cerebral Blood Flow Is Linked with Increase in Periventricular but Not Deep White Matter Hyperintensities
2007
MR assessment of cerebral vascular response: A comparison of two methods
2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
GABA-B receptor activation and conflict behaviour
1988
Lack of Effect of Pravastatin on Cerebral Blood Flow or Parenchymal Volume Loss in Elderly at Risk for Vascular Disease
2005
Transesophageal Echocardiography Is Superior to Transthoracic Echocardiography in Management of Patients of Any Age With Transient Ischemic Attack or Stroke
2006
Effect of pravastatin on cerebral infarcts and white matter lesions
2005
Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement.
2006
Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
2005
Different progression rates for deep white matter hyperintensities in elderly men and women
2004
Progression of brain atrophy and cognitive decline in diabetes mellitus
2010
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study
2002
Detection of a Soluble Form of BACE-1 in Human Cerebrospinal Fluid by a Sensitive Activity Assay
2006